← All Sponsors

SPONSOR

Boston Children's Hospital

Total Trials

13

Recruiting

13

Phases

Phase 1, Phase 2, EARLY_Phase 1, Phase 3

Conditions studied: Central Core Disease Centronuclear Myopathy Congenital Fiber Type Disproportion Multiminicore Disease Myotubular Myopathy Nemaline Myopathy Rigid Spine Muscular Dystrophy Undefined Congenital Myopathy Asthma Crohn Disease

Molecular and Genetic Studies of Congenital Myopathies

Central Core Disease

Automated Inhaler Monitoring for Asthma Medication Usage

NCT04263831 Phase 1, Phase 2

Low Dose IL-2 for the Treatment of Crohn's Disease

OnTrackCF: Engagement, Feasibility, and Acceptability Study

Cystic Fibrosis (CF)

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

Cystic Fibrosis

Balancing Emotions and Electronics: A Pilot Intervention for Preschoolers

Screen Media Use

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

Family Reported Errors and Adverse Events

NCT05744934 EARLY_Phase 1

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study

Univentricular Heart

NCT05378555 Phase 3

Oral Ketamine for Treatment of Vaso-Occlusive Pain

Vaso-occlusive Crisis

Gastric Assessment of Pediatric Patients Undergoing Surgery

Developing Fast Pediatric Imaging

Pediatric Low-grade Gliomas

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

Epilepsy in Children

Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis

Neonatal Epilepsy